GlassScriptPhysician profile
Randle William Ramsey
NPI 1104166099
$16,881.04
in general payments reported to CMS, 2019-2025
26 companies · $7,177 in 2025
The $7,177 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,824 · 2020: $1,137 · 2021: $446 · 2022: $1,685 · 2023: $1,636 · 2024: $2,974 · 2025: $7,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,145 · Food and Beverage: $3,205 · Travel and Lodging: $2,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,145.00 |
| Food and Beverage | $3,204.78 |
| Travel and Lodging | $2,438.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $8,010.07 | 2024-2025 | Unity Total Knee System, Various Products, Apollo |
| Stryker Corporation | $2,719.30 | 2019-2021 | |
| Smith+Nephew, INC. | $1,867.11 | 2020-2024 | Journey II, Legion, Or3o Dual Mobility |
| Globus Medical, INC. | $1,428.25 | 2023-2024 | Legacy Stelkast Knee, Alif Instruments (Universal), Actify |
| Exactech, INC. | $997.75 | 2019-2024 | |
| Si-Bone, INC. | $491.66 | 2022-2025 | |
| Medacta USA, INC. | $334.73 | 2020-2024 | Gmk Sphere, Masterloc |
| Ortho Development Corporation | $216.04 | 2024 | |
| Bioventus LLC | $119.64 | 2022-2024 | Durolane, Durolane |
| Orthofix Medical, INC. | $94.79 | 2019-2023 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $94.34 | 2019-2024 | Euflexxa |
| Catalyst Orthoscience | $94.32 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $79.83 | 2025 | |
| Avanos Medical | $52.68 | 2020-2022 | |
| Depuy Synthes Sales INC. | $46.03 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $40.11 | 2020-2024 | Hyalgan, Triluron, Hymovis |
| Heron Therapeutics, INC. | $38.36 | 2023-2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $35.74 | 2022-2023 | Zilretta, Exparel |
| Vericel Corporation | $21.36 | 2024 | Maci |
| Baxter Healthcare | $17.35 | 2022 | |
| Paragon 28, INC. | $17.30 | 2024 | Ankle Fracture |
| Kowa Pharmaceuticals America, INC. | $16.98 | 2023 | Seglentis |
| Sanara Medtech INC. | $14.58 | 2024 | Celleraterx |
| Kci USA, INC. | $13.18 | 2021 | |
| Ossio INC | $10.85 | 2022 | |
| Heraeus Medical, LLC. | $8.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randle Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.